Markets
CME

CME Group (CME) Beats on Q4 Earnings Estimates

Have you been eager to see how CME Group Inc.CME , one of the largest futures exchanges in the world, performed in Q4 in comparison with the market expectations? Let's quickly scan through the key facts from this Chicago, IL-based company's earnings release this morning:

An Earnings Beat

CME Group reported adjusted earnings per share of $1.14, beating the Zacks Consensus Estimate of $1.10.

Results were primarily aided by increased revenues.

How Was the Estimate Revision Trend?

You should note that the earnings estimate for CME Group depicted optimism prior to the earnings release. The Zacks Consensus Estimate advanced 1.9% to $1.10 over the last 7days.

Also, CME Group has a decent earnings surprise history.

CME Group Inc. Price and EPS Surprise

CME Group Inc. Price and EPS Surprise | CME Group Inc. Quote

Overall, the company surpassed the Zacks Consensus Estimate by an average of 1.5% in the trailing four quarters.

Revenues Came in Higher Than Expected

CME Group's revenues of $ 912.9 million increased 12.2% year over year. Also, the reported figure surpassed the Zacks Consensus Estimate of $906 million.

Key Takeaways

Average daily volume (ADV) surged 24% year over year to 16.3 million contracts in fourth-quarter 2016, with growth across five of the six product lines.

Total expenses increased 8.4% year over year at $372.7 million during the reported quarter.

Operating income improved about 15% to $540.2 million from the prior-year quarter.

As of Dec 31, 2016, long-term debt of $2.23 billion remained largely stable with the prior year period.

What Zacks Rank Says

The estimate revisions that we discussed earlier have driven a Zacks Rank #2(Buy) for CME Group . However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change. Now it all depends on what sense the just-released report makes to the analysts.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here .

Check back later for our full write up on this CME Group earnings report!

Zacks' Best Private Investment Ideas

While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.

Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CME Group Inc. (CME): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CME

Other Topics

Earnings Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More